The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays

Core Insights - The Cigna Group (NYSE:CI) announced a leadership change with CEO David Cordani retiring and being succeeded by Brian Evanko, which may surprise some investors given the timing amid a significant transformation in the company's business model [3][4] - Despite a stock decline of over 15% in the past year, Cigna's current trading price of $269.66 suggests a potential upside of 23.67%, outperforming the healthcare plans sector which fell by more than 30% [2] - Analysts remain optimistic, with nearly 85% maintaining a bullish outlook as of March 9, 2026, reflecting confidence in the company's strategic continuity [2] Leadership Change - CEO David Cordani's retirement was announced on March 3, 2026, with Brian Evanko, the former CFO and current COO, taking over as CEO [3] - Evanko is noted for his extensive institutional experience and is expected to be one of the youngest CEOs in the healthcare services industry [3] Financial Outlook - Cigna reaffirmed its 2026 earnings outlook, projecting a consolidated adjusted income from operations of at least $30.25 per share [5] - The company anticipates a pre-tax adjusted income of at least $6.9 billion for Evernorth and at least $4.5 billion for Cigna Healthcare [5] Business Model Transformation - Cigna is entering the first year of a multi-year transformation of its pharmacy benefit management (PBM) model, which is a significant change for the company [4]